October 3, 2011 Handa Pharmaceuticals, LLC (“Handa”), a specialty pharmaceutical company based in Fremont, California, today announced that it has reached an agreement with AstraZeneca to settle its U.S. patent litigation regarding Handa’s Abbreviated New Drug Application (“ANDA”) for Quetiapine Fumarate Extended-Release Tablets 50 mg., 150 mg., 200 mg., 300 mg., and 400 mg., a...Read More